PILATUS BIOSCIENCES
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Pilatus Biosciences to Present Research on PLT012 at AACR 2025 2025-04-15 20:35
Pilatus Biosciences Inc. Secures FDA Orphan Drug Designation for PLT012: A Breakthrough in Liver and Intrahepatic Bile Duct Cancer Treatment 2024-12-11 11:04
1